Conditions: Postoperative Pain
Keywords: Ropivacaine Anesthesia adjuncts clonidine laparoscopic appendectomy rectus sheath block
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 50
Healthy volunteers: no

Brief summary:
Background: Millions of pediatric patients undergo laparoscopic surgeries every year and many of them suffer significant pain and anxiety. Patient's anxiety correlates with the severity of pain and effective postoperative analgesia is necessary for optimal recovery. Single injections ultrasound guided rectus sheath blocks provide satisfactory postoperative analgesia after pediatric laparoscopic appendectomy, however they are short lived. Searching for a blocking agent that last long enough to outlast pain and has minimal side effects is a difficult task. Using a combination of drugs yielded mixed results. Few pediatric studies showed at best a weak trend in favor of clonidine prolonging analgesia after some blocks, but anxiolytic properties of clonidine were not investigated. This study will compare rectus sheath ropivacaine blocks with ropivacaine and clonidine blocks.

Methods: One hundred pediatric patients (10-17 years old) scheduled for laparoscopic appendectomy will be double blinded and randomized to the two treatment groups: the Ropivacaine Group will receive ropivacaine 0.5% (10 ml) injected bilaterally in the posterior rectus sheath, at the umbilicus location, and Ropivacaine Clonidine Group will receive ropivacaine 0.5% (10 ml) and clonidine (2mcg/kg). Post-operative analgesia will be provided with ketorolac and acetaminophen around the clock, and morphine, or/and oxycodone as needed. The primary aim is to determine if ropivacaine combined with clonidine prolongs duration of paresthesia. The secondary aims are to determine if the use of clonidine decreases anxiety level, prolongs duration of analgesia, and decreases pain severity at umbilicus laparoscopic site, reduces the need for analgesics, improves satisfaction with pain control, and is associated with complications such as oversedation, hypotension, and bradycardia.

Conclusions: Every hour of excellent analgesia count and a prolongation of block duration by at least 50% is clinical relevant. The investigators hypothesize that rectus sheath injections with ropivacaine and clonidine offer improved pain management compared to ropivacaine alone.

Detailed description:
Objective: The primary aim is to determine if ropivacaine combined with clonidine prolongs duration of paresthesia at the umbilicus. The secondary aims are to determine if the use of clonidine decreases anxiety level, prolongs duration of analgesia, decreases pain severity at the umbilicus laparoscopic site, reduces the need for pain medication, improves satisfaction with pain control, and is associated with complications such as oversedation, hypotension, and bradycardia.

Specific Aims: Aim 1 will determine if the duration of sensory block (paresthesia) after ultrasound guided single injections rectus sheath blocks performed with ropivacaine/ clonidine is longer than duration of paresthesia after rectus sheath blocks performed with ropivacaine alone. The investigators hypothesize that rectus sheath injections with ropivacaine and clonidine result in longer duration of sensory block (paresthesia) compared to ropivacaine alone.

Aim 2 will determine if the use of clonidine decreases postoperative anxiety scores and if postoperative pain scores correlate with anxiety scores. The investigators hypothesize that patient postoperative anxiety scores are lower in the Ropivacaine/Clonidine group and postoperative anxiety scores decrease more in Ropivacaine /Clonidine Group, than in the Ropivacaine Group. The investigators expect that preoperative and postoperative Numeric Rating Scale(NRS) scores reported by the patient will correlate moderately (0.3-0.49) to high (equal /or \>0.5) with preoperative and postoperative anxiety level.

Aim 3 will determine if rectus sheath injections with ropivacaine/ clonidine prolongs duration of analgesia at umbilicus instrument site, decreases analgesic consumption, improves satisfaction with pain control, and has minimal complications such as oversedation, bradycardia, and hypotension. The investigators hypothesize that rectus sheath injections with ropivacaine/ clonidine would result in longer duration of analgesia compared to ropivacaine alone, lower pain scores at umbilicus, less need for pain medication consumption for pain at umbilicus and for the first 18 hours, better satisfaction with pain control from patient, parent and nurse. The investigators expect no difference in incidence of oversedation, hypotension, and bradycardia episodes.

Background: Millions of pediatric patients undergo laparoscopic surgeries every year and many of them suffer significant pain on the day of surgery and the subsequent days. Pain is a sensory and emotional experience, modified by multiple factors, including anxiety. Patient's anxiety correlates with the severity of pain. Children that are very anxious before surgery have been found to have more postoperative pain, delayed hospital discharge, higher incidence of emergence delirium, sleep disturbances, and other maladaptive behavior changes that can last up to a few weeks following surgery. Laparoscopic appendectomy can cause significant pain and anxiety despite the minimally invasive approach. The investigators' recent completed prospective study showed that on the day after surgery, pain after laparoscopic appendectomy correlated very well with postoperative anxiety scores (Pearson coefficient =0.539; pending publication results from 133 subjects, 11-17 years old, that underwent laparoscopic appendectomy).

Effective postoperative analgesia after laparoscopic appendectomy is necessary for optimal recovery. A multimodal approach includes regional analgesia techniques, improves analgesia, and reduces side-effects from opioids use. Unfortunately, pain associated with this procedure extends after the day of surgery. Continuous peripheral nerve blocks can be effective, but are deemed excessively invasive in the context of this minimally invasive surgery. Single injection nerve blocks are appropriate, but the duration with a long acting local anesthetic is only around 12 hours, and do not match the most painful part of postoperative period, the first 24 hours. Over the last years, the challenge of developing a blocking agent that lasts long enough to outlast pain and has minimal side effects has been addressed by combining different drugs (epinephrine, clonidine, dexamethasone, tramadol, buprenorphine, midazolam, magnesium, dexmedetomidine, and ketamine) and yielded mixed results. Among these, clonidine, an alpha 2 adrenoreceptor agonist has been shown to prolong the duration of analgesia when administered in epidural space in children. Clonidine has also been added to local anesthetic for peripheral nerve blocks but its perineural use is controversial and the exact mechanism is unclear. Its action is not entirely attributed to an alpha -adrenergic effect at the nerve; rather, it is possibly secondary to the blockade of the current through hyperpolarization- activated cyclic nucleotide-gated channels, resulting in the enhancement of activity-dependent hyperpolarization.

From the limited available data, perineurally administered clonidine appears to be safe, but the results remain controversial. Adult metaanalysis have found that clonidine from 30-300 mcg prolongs the time to the first analgesic request by only 2-2.5 hrs. Furthermore, clonidine prolonged sensory and motor blockade with all local anesthetic except mepivacaine.

The pediatric literature regarding the use of clonidine for peripheral nerve blocks lags behind adult literature and is conflicting. Few small and under-powered studies showed at best a weak trend in favor of clonidine. A retrospective review of 215 patients showed that the use of clonidine prolongs the duration of infraclavicular, lumbar plexus, femoral, fascia iliaca and sciatic nerve blocks by 20-50%. However, the prolongation is block location dependent, and increased the incidence of motor block. This effect was only seen with diluted concentrations of bupivacaine 0.125% and ropivacaine 0.2%. No pediatric or adult studies were performed involving trunk blocks such as rectus sheath, transversus abdominis plane, or paravertebral nerve blocks.

Side effects reported after clonidine was administered neuraxially or perineurally are hypotension, sedation, fainting, and prolonged motor blockade. Hypotension and sedation appear to be limited up to doses of 150 mcg. However, Petroheilou et al. reported intraoperatively hemodynamic stability after administration of clonidine at 3 mcg/kg. Clonidine 1-2 mcg/kg is suggested for use with local anesthetic for single injections peripheral nerve blocks.

Clonidine can help to relieve postoperative anxiety, and subsequently improve pain control. Minimal sedation after clonidine administration can be desired for some pediatric patients. Clonidine at 2 mcg/kg prevents sevoflurane-induced agitation and can be used as premedication in children. No studies have investigated its role as an anxiolytic when added to local anesthetic for a nerve block.

The Children's Hospital of Pittsburgh of University of Pittsburgh Medical Center (CHP of UPMC) has a dedicated service to provide regional anesthesia techniques and performs peripheral nerve blocks on a regular basis. Over the last academic year, 190 patients that underwent laparoscopic appendectomy had peripheral nerve blocks (rectus sheath and transversus abdominis plane) performed for pain control. Children localized the majority of their pain to the umbilicus instrument site. This pain interferes with patients' activities such as ambulation, eating, and bedside activities. The principal investigator performed a retrospective chart review to compare postoperative analgesia from rectus sheath blocks and a combination of transversus abdominis plane and rectus sheath blocks. The postoperative opioid consumption and pain scores were similar. Since then, the primary investigator performs only ultrasound guided rectus sheath blocks for postoperative analgesia after laparoscopic appendectomy. A recent pediatric study showed that the rectus sheath blocks in combination with multimodal analgesia are effective for postoperative pain control after mentioned procedure. Unfortunately the duration of these blocks performed with maximum 20 ml of bupivacaine 0.25% with adrenaline did not outlast the most painful period. The investigators believe that rectus sheath blocks with ropivacaine 0.5% and clonidine (2 mcg/kg) will prolong the duration of blocks, can reduce postoperative pain and anxiety, facilitate discharge, and decrease unplanned hospital admission secondary to pain, and can contribute to an increased patient and family satisfaction, and decrease costs for the hospital, insurer, and the patient.

Significance: To the investigators' knowledge, this is the first study to investigate whether ropivacaine /clonidine rectus sheath blockade is a better and more complete therapeutic regimen for patients undergoing laparoscopic appendectomy. While the patients that underwent uncomplicated laparoscopic appendectomy are treated as inpatient for at least one day, CHP wants to implement early discharge strategies. Unfortunately, the pain after day of surgery can be significant and some parents can be reluctant to have their children discharged. The analgesia advices can be poorly retained. The parents can feel overwhelmed about home pain management. Some parents believe that using pain medication in childhood may lead to later drug abuse. This is concerning as parents often undermedicate their child's pain, with up to 60% of parents administering less than the prescribed analgesia on the following day after surgery discharge. A child with long lasting pain control and less anxiety from ropivacaine/clonidine rectus sheath blockade will help the parent cope with the surgical event, and can facilitate early discharge.

Additionally, patient's satisfaction with pain control is becoming an increasingly important aspect of health care reimbursements reported via the Hospital Assessment of Healthcare Providers and Systems (HCAHPS) survey. The ropivacaine/ clonidine rectus sheath blockade in combination with multimodal therapy can be better therapeutic regimen that standard of care, and can improve quality of care, increase satisfaction and save health care costs.

Arms:
arm 1: Ropivacaine Group will receive ropivacaine 0.5% (10 ml) injected bilaterally in the posterior rectus sheath, at the umbilicus location. arm 2: Ropivacaine/ Clonidine Group will receive ropivacaine 0.5% (10 ml) and clonidine (2mcg/kg) injected bilaterally in the posterior rectus sheath, at the umbilicus location.

Interventions: intervention 1: Clonidine intervention 2: Ropivacaine
Intervention descriptions: intervention 1: Only the Ropivacaine /clonidine group will receive clonidine (2mcg/kg) injected with ropivacaine. intervention 2: One hundred pediatric patients (10-17 years old) scheduled for laparoscopic appendectomy will be randomized to the two treatment groups: the Ropivacaine Group will receive ropivacaine 0.5% (10 ml) injected bilateral in Both groups will receive ropivacaine 0.5% (10 ml) injected bilaterally for the rectus sheath block

Protocol document:
Prot_SAP_000.pdf: 
1 
 
ROPIVACAINE WITH CLONIDINE FOR PEDIATRIC RECTUS 
SHEATH BLOCKS- THE MAGIC COMBINATION? - A double blinded 
prospective study 
 
03/25/2015 
 
     PRO14100075 
 
 
 
Principal Investigator:   
Mihaela Visoiu, MD  
Assistant Professor of Anesthesiology 
Director Acute Interventional Perioperative Pediatric Pain Service  
Children's Hospital of Pittsburgh of UPMC 
Children’s Hospital Drive 4401 Penn Avenue, Pittsburgh, PA, 15224 
 412-692-5260 
              visoium@upmc.edu 
 
Co-Investigators: 
 
 
 
Stefan Scholz, MD 
Assistant Professor of Surgery, Pediatric Surgery, Director of Minimally Invasive 
Surgery,  
Children’s Hospital of Pittsburgh of UPMC 
 Children’s Hospital Drive, 4401 Penn Avenue, Pittsburgh, PA 15224 
412-692-8778  
 stefan.scholz@chp.edu 
 
 
 
 
 
 
 
 
 
 
 
 
 


2 
 
 
 
 
 
A. ABSTRACT 
Appendectomy is one of the most frequently performed emergency surgeries in 
children. Although the laparoscopic technique is minimally invasive and has become a popular 
approach for performing appendectomies, it is still associated with a significant amount of pain 
and anxiety in children. To improve analgesia and decrease postoperative anxiety in children 
undergoing laparoscopic appendectomies, we plan to develop a multimodal approach for pain 
control that includes peripheral nerve blocks, a regional analgesia technique. 
 Selecting the ideal nerve block for laparoscopic appendectomies is a difficult task; nerve 
blocks traditionally contain only local anesthetic, and it is challenging to find a local anesthetic 
that not only possesses minimal side effects, but also outlasts pain, relieves anxiety and 
improves satisfaction with pain control. For instance, even though single injection ultrasound 
guided rectus sheath blocks provide satisfactory postoperative analgesia after pediatric 
laparoscopic appendectomy, they tend to be short-lived. To overcome the limitations inherent 
to local anesthetics, adjuvant medications have been added to nerve blocks, with the hope that 
the resulting combination will provide patients with better pain control. Clonidine— an alpha 2 
adrenoreceptor agonist—is one such medication, and a few small pediatric studies have shown 
a weak trend in favor of clonidine prolonging analgesia for some blocks, without examining its 
anxiolytic properties. Our preliminary experience supports the notion the clonidine may assist 
with pain control, as we have found that a ropivacaine/ clonidine rectus sheath blockade 
increases the duration of sensory blockade and analgesia. The goal of this pilot study is to build 
upon these observations and examine whether ropivacaine/clonidine is effective at prolonging 
analgesia beyond the effects of ropivacaine alone for laparoscopic appendectomies. 
Additionally, we plan to investigate the underlying mechanism (i.e. anxiety reduction) that may 
make this combination better suited for postoperative pain control. Ultimately, results from our 
study will help us devise better therapeutic regimens for our patients. 
One hundred pediatric patients (10-17 years old) scheduled for laparoscopic appendectomy 
will be randomized into one of two treatment groups—the Ropivacaine Group or the 
Ropivacaine/Clonidine group—after which they will receive bilateral injections of the 
corresponding blocking agents in the posterior rectus sheath, at the umbilicus location. Patients 
in the Ropivacaine Group will receive ropivacaine 0.5% (20 ml), while patients in the 
Ropivacaine/ Clonidine Group, will receive ropivacaine 0.5% (20 ml) and clonidine (2mcg/kg).  
The overall hypothesis is that the ropivacaine combined with clonidine administered via 
single injection ultrasound guided bilateral rectus sheath blocks is a more complete and feasible 
pain control approach than ropivacaine alone. We will test this hypothesis by pursuing the 
following specific aims: 1) determine if the ropivacaine/clonidine combination is superior in 
providing long-lasting analgesia to ropivacaine alone; and 2) advance the understanding of 
ropivacaine/clonidine rectus sheath blockade, and determine if this combination significantly 
improves satisfaction with pain control due to psychological benefits of clonidine.  


3 
 
We view this innovative study as a first step in developing an evidence-based 
therapeutic pain regimen for laparoscopic appendectomy.  Every hour of effective analgesia 
counts, as it improves quality of care and reduces health care costs. Upon successful 
completion of this project, we will seek further support to prospectively validate this 
combination for other trunk blocks as well as various surgical procedures. The safety of 
ropivacaine/clonidine blockade should be evaluated in large scale prospective studies.  
  
 
 
B. SPECIFIC AIMS AND METHODS TO BE EMPLOYED 
 
Laparoscopic appendectomy is a popular and minimally invasive technique is used for 
removing the appendix, but it is associated with significant pain and anxiety in pediatric 
populations. The goal of this pilot study is to examine whether ropivacaine/clonidine is effective 
at prolonging analgesia beyond the effects of ropivacaine alone and to investigate the 
underlying mechanism (i.e. anxiety reduction) that may make this combination better suited for 
postoperative pain control, so that better therapeutic regimens can be offered to our patients. 
The overall hypothesis is that the ropivacaine /clonidine rectus sheath blockade is a more 
complete and feasible pain control approach after laparoscopic appendectomy. This hypothesis 
will be tested by the following specific aims: 
Aim 1. To determine if the ropivacaine/clonidine combination can prolong analgesia, we will 
determine if ropivacaine/clonidine rectus sheath blockade   is superior in providing long-lasting 
analgesia compared to ropivacaine alone.  Aim 1A will compare duration of paresthesia at the 
umbilicus instrument site. Aim 1B will compare duration of analgesia at the same location.  
The methodology will be the following: 
Aim 1A: On the day of surgery, patients will be asked about paresthesia and loss of sensation 
around the umbilicus. We will document the time when normal sensation returns following the 
administration of the block. The time elapsed (in minutes) between rectus sheath blockade and 
the point at which normal sensation returns will be compared between the groups.   
Aim 1B: Every 2 hours, we will question the patients regarding their need for pain medication 
and obtain their Numeric Rating Scale (NRS) pain scores for umbilicus incisional pain. We will 
document when the patient needs pain medication. The time elapsed (in minutes) from the 
rectus sheath blockade until the first request for umbilicus pain medication, as well as NRS pain 
scores will be compared between groups.  
Hypothesis: 
We hypothesize that rectus sheath injections with the ropivacaine/clonidine combination will 
be superior in providing long lasting analgesia compared to ropivacaine alone, increasing the 
duration of sensory block and analgesia, and lowering pain scores at the umbilicus incision.  
Aim 2. We will determine if any improvements we observe in pain control satisfaction with the 
ropivacaine/clonidine combination can be attributed to clonidine’s ability to reduce anxiety. 
Aim 2A will compare between the two groups patient, parent, and nurse NRS satisfaction 
scores and correlate them with post-op scores on the state-anxiety component of the State-
Trait Anxiety Inventory for Children (STAIC S – Anxiety).  Aim 2B will compare postoperative 


4 
 
STAIC S – Anxiety scores between the two groups. Aim 2C will compare within the two groups 
the difference between the pre and post- op STAIC S Anxiety scores to show if 
ropivacaine/clonidine is more effective at reducing anxiety. 
The methodology will be the following: 
Aim 2A: NRS pain control satisfaction scores from patient, parent and nurse will be collected at 
the completion of the study. State-Trait Anxiety Inventory for Children (STAIC S – Anxiety) 
questionnaires will be administered to both groups before surgery, and at hour 6 after rectus 
sheath injections. Post-op anxiety scores in each group will be correlated with satisfaction 
scores.Aim 2B: The postoperative STAIC S – Anxiety scores will be compared between the 2 
groups. Aim 2C: The pre-op STAIC S Anxiety scores will be compared with post- op STAIC S 
Anxiety within each group. 
Hypothesis:   
We hypothesize that patients, parents and nurses will experience more pain control satisfaction 
with the ropivacaine/clonidine combination than with the ropivacaine alone, not only because 
the combination will provide longer lasting analgesia, but also because clonidine’s power to 
reduce anxiety will lead to a concomitant decrease in pain.  
 
C. BACKGROUND  
 
 Appendectomy is one of the most common emergency surgeries performed in children, 
especially in adolescents and teens. (1) At present, the laparoscopic technique has become a 
popular approach for performing appendectomies, (1)as it is minimally invasive and has been 
shown to improve patients’ outcomes. (2). Despite these advantages, children often experience 
significant pain (3) and anxiety during these laparoscopic procedures that extends after the day 
of surgery, particularly those who are particularly anxious before surgery. Indeed, children who 
are highly anxious prior to surgery tend to have more postoperative pain, delayed hospital 
discharge, higher incidence of emergence delirium, sleep disturbances, and other maladaptive 
behavior changes that can last up to a few weeks following surgery. (4), (5)    
 
Effective postoperative analgesia after laparoscopic appendectomy is necessary for 
optimal recovery. (3) By simultaneously improving analgesia and reducing side-effects from 
opioid use, a multimodal approach that includes peripheral nerve blocks—a form of regional 
analgesia—could form the crux of an effective pain control regimen for patients undergoing 
laparoscopic appendectomy. Despite the promise of such an approach, finding a nerve block 
that is suitable for patients undergoing laparoscopic appendectomies is challenging. Nerve 
blocks typically consist of local anesthetic alone, and it is difficult to find a local anesthetic with 
both minimal side effects and ability to combat pain and anxiety for extended periods of time. 
For instance, even though single injection nerve blocks (such as rectus sheath blocks) in 
combination with multimodal analgesia for laparoscopic appendectomy are helpful and 
minimally invasive, they do not last over the course of the most painful part of postoperative 
period, the first 24 hours. (6) By contrast, continuous peripheral nerve blocks can provide 
enduring analgesia, but they are costly and deemed excessively invasive in the context of this 
minimally invasive surgery.  
 
To overcome the challenge of developing a blocking agent that has both minimal side 
effects and duration long enough to outlast the pain, additional substances (epinephrine, 


5 
 
clonidine, dexamethasone, tramadol, buprenorphine, midazolam, dexmedetomidine, and 
ketamine) have been added to the local anesthetics comprising the nerve blocks. (7) (8) Among 
the adjuvants, clonidine—an alpha 2 adrenoreceptor agonist—has been shown to prolong the 
duration of analgesia when administered in the epidural space in children.  (9), (10)  Clonidine 
has also been added to local anesthetic for peripheral nerve blocks, but its perineural use is 
controversial and its exact mechanism of action is unclear; from the limited available data, 
perineurally administered clonidine appears to be safe, with an efficacy that has yet to be 
determined. Meta-analyses conducted in adult populations have found that clonidine from 30-
300 mcg prolongs the time to the first analgesic request by only 2-2.5 hrs. (11) (12) 
The pediatric literature regarding the use of clonidine for peripheral nerve blocks lags 
behind adult literature and is conflicting. Few small and under-powered studies showed at 
best a weak trend in favor of clonidine.  (13), (14) (15) (16), (17), (18), (19) A retrospective 
review of 215 patients showed that the use of clonidine in conjunction with local anesthetic is 
effective in some locations but not others, prolonging analgesia in infraclavicular, lumbar 
plexus, femoral, fascia iliaca and sciatic nerve blocks by 20-50%. The increased duration of 
sensory blockade, however, was also associated with an increased the incidence of motor 
block. (16) No pediatric or adult studies were performed involving trunk blocks such as rectus 
sheath, transversus abdominis plane, or paravertebral nerve blocks. Side effects reported after 
neuroaxially or peripherally administered clonidine in conjunction with local anesthetic are 
hypotension, sedation, fainting, and prolonged motor blockade.  (12) (16), (11) (13) Clonidine 
1-2 mcg/kg is suggested for use with local anesthetic for single injections peripheral nerve 
blocks. (20) 
Minimal sedation can be desired for some pediatric patients that underwent surgeries. 
Clonidine produces effective sedation for patients on mechanical ventilation that can be 
uncomfortable because anxiety, pain and endotracheal intubation. (21) Clonidine at 2 mcg/kg 
prevents sevoflurane-induced agitation (22), (23) and can be used as premedication in 
children. (24), (25) Oral clonidine can  relieve postoperative anxiety, and subsequently improve 
pain control. (26) No studies have investigated its role as an anxiolytic when added to local 
anesthetic for a nerve block. 
 
Preliminary studies: 
The Children’s Hospital of Pittsburgh of University of Pittsburgh Medical Center (CHP of 
UPMC) has a dedicated service that performs peripheral nerve blocks on a regular basis. Over 
the last academic year, 190 patients (10-17 years old, 126 patients) that underwent 
laparoscopic appendectomy had peripheral nerve blocks (rectus sheath and transversus 
abdominis plane).  Our experience suggests that children localized the majority of their pain to 
the umbilicus instrument site. (6)  To treat this pain is crucial, as this pain interferes with 
eating, bedside activities and ambulation,   and can delay discharge.   
 Our preliminary study (retrospective chart of 50 patients that underwent laparoscopic 
appendectomy) demonstrates that rectus sheath blocks, which target pain at the umbilicus 
instrument, are as effective as a combination of transversus abdominis plane and rectus 
sheath blocks, which target pain at all instrument sites. This is an important finding, as it 
means that instead of dividing the amount of local anesthetic delivered between four sites, 


6 
 
more anesthetic can be delivered bilaterally to a single location. This can result in analgesia 
that lasts around 12 hours, which is relatively short for our purposes but still an improvement. 
Dr Visoiu’s prospective study demonstrates that postoperative pain scores after 
laparoscopic appendectomies correlate very well with postoperative anxiety (Pearson 
coefficient =0.539;133 subjects, 11-17 years old). Patients that received regional anesthesia for 
laparoscopic surgeries reported less anxiety after surgery (Spearman coefficient = -0.143, p = 
0.042; pending publication; 202 subjects, 11-17 years old). The use of single injection nerve 
blocks predicts less postoperative pain (p=0.04), better mood (p=0.009), less catastrophizing 
thoughts about pain (p=0.007). 
  
Based on our experience and preliminary studies, our goal is to treat the patient 
comprehensively, rather than just the pain itself; whenever possible, we should seek to 
decrease postoperative anxiety and improve satisfaction with pain control.  Recently, we 
added clonidine to ropivacaine for rectus sheath blockade and noticed longer lasting 
paresthesia and analgesia (18-22 hours). Because we did not investigate the anxiolytic 
properties of clonidine, we do not know if the small increase in analgesia we observed is 
clinically relevant.  The potential benefits for patients, families, and medical providers need to 
be investigated. 
 
Laparoscopic appendectomy is associated with significant pain and anxiety in pediatric 
populations. The goal of our study is thus to investigate whether the combination of 
ropivacaine and clonidine is effective in prolonging analgesia beyond the duration observed 
with ropivacaine alone for pediatric patients undergoing these procedures. Additionally, we 
will explore the underlying mechanism that may make this combination better equipped for 
postoperative pain control, so that we can devise more optimal pain control regimens. Our 
hypothesis is that ropivacaine/clonidine is a significantly better therapeutic regimen for our 
patients. The primary aim is to determine if the ropivacaine/clonidine combination is superior 
in providing long-lasting analgesia. The secondary aim is to determine if the 
ropivacaine/clonidine combination significantly improves satisfaction with pain control due to 
the psychological benefits of clonidine. 
 
D. RESEARCH DESIGNS AND METHODS  
Overview   
This is a double blinded prospective study. Following University of Pittsburgh IRB 
approval, 100 pediatric patients will be recruited. Following parental written consent and 
patient assent, these patients will be included in the study.  
 
Patient eligibility 
Inclusion criteria will consist of 1) age 10-17 years, 2) scheduled for elective laparoscopic 
appendectomy, 3) weight >/=34kg, 4) complete postoperative questionnaires. Exclusion criteria 
will be 1) patients younger than 10 years and 18 years or older, 2) weight < 34 kg, 3) weight 
>/=100 kg, 4) patient and family refusal, 5) non-English-speaking patients and families, 6) 
cognitive impairment, 7) developmental delay,  8) allergies to medications used in the study 
(hydromorphone, oxycodone, acetaminophen, ketorolac, ropivacaine, and clonidine), 9) need 
for opioids via a patient controlled analgesia device, 10) patients with a positive pregnancy test, 
and 11) local infection at planned injection sites 


7 
 
The following patients will be excluded from the study: 1) patients with failed rectus 
sheath blocks, 2) patients that require opioids via a patient controlled analgesia device, 3) 
patients with laparoscopic procedure converted to open, 4) patients that will not be able to 
place the time of return to normal sensation within 1 hour of its occurrence (e.g. sleeping), and 
5) patients with no follow-up possible. The patients that will be discharged home before the 
resolution of paresthesia will be excluded from analysis of the first aim. 
 
Randomization: 
The operating room pharmacy will perform the randomization using a computer-
generated random number table. The study medications will be labeled as study drug and 
released in identical syringes with a volume of 11 ml each. Two syringes will be released per 
patient. Each syringe for Ropivacaine Group (total 2) will contain 10 ml of ropivacaine 0.5% and 
1ml of normal saline. Each syringe for the Ropivacaine/ Clonidine Group ( total 2) will contain 
10 ml of  ropivacaine 0.5 %, 1 mcg/kg (0.01 ml/kg) of clonidine (100 mcg =1 ml) and normal 
saline for a total volume of 11 ml. Patients and all members of the care team, except the 
pharmacist, will be blinded to group allocation. 
 
Intraoperative Study Protocol: 
In the operating room, standard anesthesia monitors will be connected and general 
anesthesia will be performed as per the anesthesiologist’s standard of care.  At the completion 
of surgery, acetaminophen iv and ketorolac will be administered by the anesthesia provider. 
Dexmedetomidine will not be administered during anesthesia or after the completion of 
anesthesia. A member of CHP Acute Interventional Perioperative Pain Service (AIPPS) – 
attending or fellow will perform all bilateral ultrasound guided rectus sheath blocks  as per 
CHP standard of care using the study drug. The surgeon will not infiltrate the local anesthetic 
at the laparoscopic instrument sites.  
 
Postoperative Study Protocol: 
For the following 24 hours, the analgesic regimen will include ketorolac every 6 hours 
(if not contraindicated by surgeon), acetaminophen iv every 6 hours, oxycodone by mouth as 
needed for pain, every 4 hours, and hydromorphone iv as needed for pain, every 2 hour.  
In the postoperative period the patients will be asked to complete a few questionnaires 
created for this study. The nurse taking care of the patient, principal investigator, one of the 
co-investigators, or the research assistant will do the assessment. Starting in the PACU, the 
patients will be questioned about the presence of paresthesia around the umbilicus 
instrument site (“is the area around your belly button numb”) and the umbilical pain severity 
using NRS scale (0 being no pain and 10 the worst imaginable pain). They will also be asked 
about their need for pain medication for umbilical pain as well as the amount of pain 
medication they have consumed for pain in that region.   The assessment will continue on the 
floor every 2 hours until complete resolution of paresthesia at the umbilicus or until the 
patient is discharged home. The state version (S-anxiety) of the State-Trait Anxiety Inventory 
for Children (STAIC) will be administered to measure patient anxiety before surgery after the 
consent is done and 6 hours after rectus sheath injections.   At the completion of the study, 


8 
 
the patient’s, parent’s, and nurse’s satisfaction with pain control will be investigated using an 
NRS scale (0 being very unsatisfied and 10 being very satisfied). 
 
 
E. STATISTICS: ASSESSMENT OF ADEQUACY OF SAMPLE SIZE 
Descriptive statistics will be presented as frequencies (percentages, %) for categorical 
data or as mean ± standard deviation (SD) or median and interquartile range for normally or 
non-normally distributed continuous data, as appropriate. Examination of normal distribution 
assumption for continuous data will be determined by q-q plots and histograms. Two sample T-
Test or Wilcoxon-Mann-Whitney test will be performed to determine differences between 
groups for normally or non-normally distributed continuous data, respectively. Pearson’s chi-
square or Fisher’s exact test, as appropriate, will be used to compare the frequency distribution 
of categorical variables between the groups. We will compute Pearson correlation coefficient 
between NRS pain scores and the anxiety scores. If the assumptions for the parametric test are 
not met, a nonparametric alternative will be used (i.e. Spearman correlation coefficient). 
 
Sample Size and Power:  
The target sample size was calculated with the assumption that the duration of block in 
the group with ropivacaine only is 720 minutes ± 288 minutes and in the group with 
ropivacaine and clonidine the duration is 1080 minutes ± 432 minutes. The difference would 
be clinically relevant if the duration of blocks with ropivacaine and clonidine will be at least 
50% or more than the duration of blocks with local anesthetic only. Assuming a power of 80%, 
a level of significance of 0.05, mean and SD as above, only 12 patients would be required in 
each group.  Allowing for a 400% loss arising from patient dropout, unsuccessful block, 
incomplete follow up because of discharge home on the day of surgery, and inability to 
determine when paresthesia wears off, we plan to recruit 50 patients in each group, for a total 
of 100 patients.  We estimate that this sample size of 100 patients would provide 80% power 
to detect a difference as small as 23% in the duration of paresthesia between these 2 groups. 
 
  
F. SIGNIFICANCE AND APPLICABILITY 
To our knowledge, this is the first study to investigate if ropivacaine /clonidine rectus 
sheath blockade is a better and more complete therapeutic regimen for patients undergoing 
laparoscopic appendectomy.  While the patients that underwent uncomplicated laparoscopic 
appendectomy are treated as inpatients for at least one day, CHP wants to implement early 
discharge strategies. Unfortunately, the pain after the day of surgery can be significant (3), 
and causes some parents to be reluctant to have their children discharged. Analgesia advice 
can be poorly retained (27) and parents can feel overwhelmed about home pain 
management.  Furthermore, some parents believe that using pain medication in childhood 
may lead to later drug abuse. (28)  This is particularly concerning, as parents often 
undermedicate their child’s pain, with up to 60% of parents administering less than the 
prescribed analgesia on the following day after surgery discharge.  (29), (30) A child with long 
lasting pain control and less anxiety from ropivacaine/clonidine rectus sheath blockade would 
help the parent better cope with the surgical event, facilitating early discharge.   


9 
 
We would like to mention that patient’s satisfaction with pain control is becoming an 
increasingly important aspect of health care reimbursements reported via the Hospital 
Assessment of Healthcare Providers and Systems (HCAHPS) survey.  The ropivacaine/ clonidine 
rectus sheath blockade in combination with multimodal therapy can serve as a better 
therapeutic regimen than the standard of care, improving quality of care, increasing 
satisfaction and saving health care costs.   
 
  
G. POTENTIAL LIMITATIONS AND FUTHER DEVELOPMENT 
First, although we will record the pain scores and analgesics consumption for pain located 
at the umbilicus instrument size, our data is subject to some bias. These predictors of analgesia 
may be prone to misclassification. The visceral/gas pain can be confused with incisional pain, 
and some patients will need analgesics for another type of pain and location.  We believe that   
using paresthesia as surrogate for analgesia is a better and more complete indicator of duration 
of analgesia.  
 Second, preoperative anxiety may reflect in postoperative anxiety scores. However, we 
believe that comparing preoperative and postoperative anxiety and pain scores will help 
minimize this   bias. 
Third, other medical researchers maybe interested in the ropivacaine/clonidine 
effectiveness on trunk blocks (paravertebral, transversus abdominis plane blocks, ilioinguinal) 
for other surgical procedures. Upon successful completion of this project, we will seek 
further support to prospectively validate this combination for other trunk blocks as well as 
various surgical procedures. Finally, we acknowledge that to assess the safety, the 
participation of a substantially larger numbers of centers is required.   
 
 
 
 
 
 
 


10 
 
H. REFERENCES 
1. 
Masoomi H, Nguyen NT, Dolich MO, Mills S, Carmichael JC, Stamos MJ. Laparoscopic 
appendectomy trends and outcomes in the United States: data from the Nationwide Inpatient 
Sample (NIS), 2004-2011. The American surgeon. 2014;80(10):1074-7. PubMed PMID: 
25264663. 
2. 
Esposito C, Calvo AI, Castagnetti M, Alicchio F, Suarez C, Giurin I, et al. Open versus 
laparoscopic appendectomy in the pediatric population: a literature review and analysis of 
complications. Journal of laparoendoscopic & advanced surgical techniques Part A. 
2012;22(8):834-9. PubMed PMID: 23039707. 
3. 
Liu Y, Seipel C, Lopez ME, Nuchtern JG, Brandt ML, Fallon SC, et al. A retrospective study 
of multimodal analgesic treatment after laparoscopic appendectomy in children. Paediatric 
anaesthesia. 2013;23(12):1187-92. PubMed PMID: 24112856. 
4. 
Kain ZN, Caldwell-Andrews AA, Maranets I, McClain B, Gaal D, Mayes LC, et al. 
Preoperative anxiety and emergence delirium and postoperative maladaptive behaviors. Anesth 
Analg. 2004;99(6):1648-54, table of contents. PubMed PMID: 15562048. 
5. 
Kain ZN, Mayes LC, Caldwell-Andrews AA, Karas DE, McClain BC. Preoperative anxiety, 
postoperative pain, and behavioral recovery in young children undergoing surgery. Pediatrics. 
2006;118(2):651-8. PubMed PMID: 16882820. 
6. 
Hamill JK, Liley A, Hill AG. Rectus sheath block for laparoscopic appendicectomy: a 
randomized clinical trial. ANZ journal of surgery. 2015. PubMed PMID: 25581711. 
7. 
Abdallah FW, Johnson J, Chan V, Murgatroyd H, Ghafari M, Ami N, et al. Intravenous 
dexamethasone and perineural dexamethasone similarly prolong the duration of analgesia after 
supraclavicular brachial plexus block: a randomized, triple-arm, double-blind, placebo-
controlled trial. Regional anesthesia and pain medicine. 2015;40(2):125-32. PubMed PMID: 
25629321. 
8. 
Bailard NS, Ortiz J, Flores RA. Additives to local anesthetics for peripheral nerve blocks: 
Evidence, limitations, and recommendations. American journal of health-system pharmacy : 
AJHP : official journal of the American Society of Health-System Pharmacists. 2014;71(5):373-
85. PubMed PMID: 24534592. 
9. 
Akin A, Ocalan S, Esmaoglu A, Boyaci A. The effects of caudal or intravenous clonidine on 
postoperative analgesia produced by caudal levobupivacaine in children. Paediatric anaesthesia. 
2010;20(4):350-5. PubMed PMID: 20158620. 
10. 
Rochette A, Troncin R, Raux O, Dadure C, Lubrano JF, Barbotte E, et al. Clonidine added 
to bupivacaine in neonatal spinal anesthesia: a prospective comparison in 124 preterm and term 
infants. Paediatric anaesthesia. 2005;15(12):1072-7. PubMed PMID: 16324026. 
11. 
McCartney CJ, Duggan E, Apatu E. Should we add clonidine to local anesthetic for 
peripheral nerve blockade? A qualitative systematic review of the literature. Regional anesthesia 
and pain medicine. 2007;32(4):330-8. PubMed PMID: 17720118. 
12. 
Popping DM, Elia N, Marret E, Wenk M, Tramer MR. Clonidine as an adjuvant to local 
anesthetics for peripheral nerve and plexus blocks: a meta-analysis of randomized trials. 
Anesthesiology. 2009;111(2):406-15. PubMed PMID: 19602964. 
13. 
Petroheilou K, Livanios S, Zavras N, Hager J, Fassoulaki A. Sciatic lateral popliteal block 
with clonidine alone or clonidine plus 0.2% ropivacaine: effect on the intra-and postoperative 
analgesia for lower extremity surgery in children: a randomized prospective controlled study. 


11 
 
BMC anesthesiology. 2012;12:2. PubMed PMID: 22297020; PubMed Central PMCID: 
PMCPMC3353170. 
14. 
Trifa M, Ben Khalifa S, Jendoubi A, Zribi N, Regaya T, Engelhardt T. Clonidine does not 
improve quality of ropivacaine axillary brachial plexus block in children. Paediatric anaesthesia. 
2012;22(5):425-9. PubMed PMID: 22309507. 
15. 
Dagher C, Yazigi A, Rkaibe N. Clonidine as adjuvant for bupivacaine in ilioinguinal block 
does not prolong postoperative analgesia in pediatric and also in adult patients. Paediatric 
anaesthesia. 2006;16(2):224-5; PubMed PMID: 16430430. 
16. 
Cucchiaro G, Ganesh A. The effects of clonidine on postoperative analgesia after 
peripheral nerve blockade in children. Anesth Analg. 2007;104(3):532-7PubMed PMID: 
17312203. 
17. 
Ivani G, Conio A, De Negri P, Eksborg S, Lonnqvist PA. Spinal versus peripheral effects of 
adjunct clonidine: comparison of the analgesic effect of a ropivacaine-clonidine mixture when 
administered as a caudal or ilioinguinal-iliohypogastric nerve blockade for inguinal surgery in 
children. Paediatric anaesthesia. 2002;12(8):680-4. PubMed PMID: 12472703. 
18. 
Kaabachi O, Zerelli Z, Methamem M, Abdelaziz AB, Moncer K, Toumi M. Clonidine 
administered as adjuvant for bupivacaine in ilioinguinal-iliohypogastric nerve block does not 
prolong postoperative analgesia. Paediatric anaesthesia. 2005;15(7):586-90. PubMed PMID: 
15960643. 
19. 
Sharpe P, Klein JR, Thompson JP, Rushman SC, Sherwin J, Wandless JG, et al. Analgesia 
for circumcision in a paediatric population: comparison of caudal bupivacaine alone with 
bupivacaine plus two doses of clonidine. Paediatric anaesthesia. 2001;11(6):695-700. PubMed 
PMID: 11696146. 
20. 
Lonnqvist PA. Adjuncts should always be used in pediatric regional anesthesia. Paediatric 
anaesthesia. 2015;25(1):100-6. PubMed PMID: 25230242. 
21. 
Srivastava U, Sarkar ME, Kumar A, Gupta A, Agarwal A, Singh TK, et al. Comparison of 
clonidine and dexmedetomidine for short-term sedation of intensive care unit patients. Indian 
journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical 
Care Medicine. 2014;18(7):431-6. PubMed PMID: 25097355; PubMed Central PMCID: 
PMCPMC4118508. 
22. 
Kulka PJ, Bressem M, Tryba M. Clonidine prevents sevoflurane-induced agitation in 
children. Anesth Analg. 2001;93(2):335-8, 2nd contents page. PubMed PMID: 11473855. 
23. 
Mukherjee A, Das A, Basunia SR, Chattopadhyay S, Kundu R, Bhattacharyya R. Emergence 
agitation prevention in paediatric ambulatory surgery: A comparison between intranasal 
Dexmedetomidine and Clonidine. Journal of research in pharmacy practice. 2015;4(1):24-30. 
PubMed PMID: 25710047; PubMed Central PMCID: PMCPMC4326968. 
24. 
Nishina K, Mikawa K. Clonidine in paediatric anaesthesia. Current opinion in 
anaesthesiology. 2002;15(3):309-16. PubMed PMID: 17019218. 
25. 
Bergendahl H, Lonnqvist PA, Eksborg S. Clonidine in paediatric anaesthesia: review of the 
literature and comparison with benzodiazepines for premedication. Acta Anaesthesiol Scand. 
2006;50(2):135-43. PubMed PMID: 16430532. 
26. 
Hidalgo MP, Auzani JA, Rumpel LC, Moreira NL, Jr., Cursino AW, Caumo W. The clinical 
effect of small oral clonidine doses on perioperative outcomes in patients undergoing abdominal 
hysterectomy. Anesth Analg. 2005;100(3):795-802, table of contents. PubMed PMID: 15728070. 


12 
 
27. 
Hegarty M, Calder A, Davies K, Shave M, Christiansen E, Meyer T, et al. Does take-home 
analgesia improve postoperative pain after elective day case surgery? A comparison of hospital 
vs parent-supplied analgesia. Paediatric anaesthesia. 2013;23(5):385-9. PubMed PMID: 
23167309. 
28. 
Fortier MA, Kain ZN. Treating perioperative anxiety and pain in children: a tailored and 
innovative approach. Paediatric anaesthesia. 2015;25(1):27-35. PubMed PMID: 25266082; 
PubMed Central PMCID: PMCPMC4261033. 
29. 
Finley GA, McGrath PJ, Forward SP, McNeill G, Fitzgerald P. Parents' management of 
children's pain following 'minor' surgery. Pain. 1996;64(1):83-7. PubMed PMID: 8867249. 
30. 
Hamers JP, Abu-Saad HH. Children's pain at home following (adeno) tonsillectomy. 
European journal of pain. 2002;6(3):213-9. PubMed PMID: 12036308. 
 
 STUDY DURATION: 
The study period is from the time of the consent until postoperative block resolution assessment 
is completed and estimated to be 18-24 hours for each patient. 
TIMELINE: The proposal will not extend 2 years. 
VERTEBRATE ANIMALS:  Not applicable for this project 
INSTITUTIONAL APPROVAL: IRB will be needed